A safe, easy-to-administer neuromodulation technique targets and reduces post-anesthesia agitation, offering a novel drug-free perioperative option Chinese Medical Journals Publishing House Co., Ltd.
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
“We are deeply grateful to INOVAIT for supporting a vision where AI‑enabled, image‑guided therapies like TULSA-PRO are not only developed in Canada, but lead the world,” added Mathieu Burtnyk, ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ('Profound” or the 'Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will ...
When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
A recent prospective study highlights the substantial burden of late RT-related genitourinary complications among men with ...
Super Bowl ad puts male reproduction gland in the spotlight. But is that specific prostate test the best method based on experts' recommendation?
Cancer charity highlights apparent ‘postcode lottery’ of testing and diagnoses across different regions seen in study Prostate cancer is now the most commonly diagnosed form of cancer across the UK, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results